Musa Fares Alzahrani 
=======================================
Personal information:
Date of Birth: 2/5/1983 
Nationality: Saudi
Marital status: Married
Address: King Saud University, Medicine department, division of hematology, Riyadh, Saudi Arabia. 
Email: malzahrani@ksu.edu.sa
=======================================================================

Academic Qualifications:

    2016-2017: Master of Health Science (c) (MHSc), University of British Colombia, Vancouver, Canada. 
    2016-2017: Post graduate fellowship program in Bone Marrow Failure and Myelodysplastic Syndromes, University of British Columbia, Vancouver, Canada.  
    2016: American Board of Hematology. 
    2015-2016: Post graduate fellowship program in Leukemia and Bone Marrow Transplant, Vancouver General Hospital, University of British Columbia, Vancouver, Canada. 
    2014-2016: Post graduate fellowship program in Malignant Hematology: lymphoma rotations at the BC Cancer Agency (BCCA), malignant hematology clinics, Leukemia and Bone Marrow Transplant, and clinical research.
    2014: Fellow in the Royal College of Physicians and Surgeons of Canada (FRCPC) in the division of medicine granted on April 14/2014
    2014: Subspecialty certificate in Hematology by the Royal College of Physicians and Surgeons of Canada
    2013: Certified in Internal Medicine by the Royal College of Physicians and Surgeons of Canada
    2012: American Board of Internal medicine (ABIM)
    2001 - 2007: MBBS, from the Medical school at King Saud University, Riyadh, KSA.
    1998 - 2001: High School Diploma, Nasba high school, Baha, KSA  
   
Employment:

    Demonstrator/Academic position in college of Medicine, King Saud University, Riyadh, 2008 until present.
    Resident at King Khalid University Hospital (KKUH), 2008.
    Internal medicine resident at University of British Columbia from 2009-2012.

Experience in Hematology:

    One year fellowship program in Bone marrow failure and myelodysplastic syndromes at Vancouver General Hospital. 
    Two year program of intensive malignant hematology training including clinical lymphoma rotations at the BC Cancer Agency (BCCA), lymphoma pathology rotation at the BCCA, one year clinical fellowship in Leukemia and Blood & Marrow Transplant (BMT) at UBC, laboratory rotations at the cytogenetics lab at Vancouver General Hospital (VGH), flowcytometry lab at VGH and BCCA, and cryogenic lab at the BCCA.
    Two year hematology fellowship program accredited by the royal college of physician and surgeons in Canada.  
    During Residency
o    (Hematology) Sep 2009 – Oct 2009: St.Paul’s Hospital, Vancouver.    
o    (Hematology) Jan 2011 – Feb 2011: Vancouver General Hospital.
o    (Hematopathology) Mar 2011 – Apr 2011: King Abdulaziz University Hospital, Jeddah, Saudi Arabia
o    (Medical Oncology-lymphoma group) May 2011 – Jun 2011: BC Cancer Agency, Vancouver.
    During internship 2007-2008:
o    (Medicine Rotation) Jul 2007 – Aug 2007: Hematology oncology at KKUH.    
o    (Elective Rotation) Dec 2008: Adult hematology oncology at King Faisal Specialist Hospital and Research center.
o    (Pediatric Rotation) May 2008: Pediatric hematology oncology at King Fahd Medical City, Riyadh.

Memberships:

    Member of the Saudi scientific hematology society.
    Active member of American Society of Hematology. 

Prizes and Awards:        

    Awarded the 2016 Best Presentation by a Resident or Fellow at the Leukemia/BMT Research Day.
    Awarded the 2015 BC Cancer Agency Medical Oncology Resident Research Day prize for best Presentation.
    Winners of Quality Improvement (QI) awards at the fifth annual Resident Day on Quality Improvement. (VCH patient safety and best practice award for medical residents, December 1st/2010).
    Honored by the Saudi Bureau for excellent performance multiple times for all scholarship’s periods: (internal medicine training, hematology training, malignant hematology and BMT training and the Master degree)  
    Second class Honor in Medicine and Surgery MBBS from King Saud University, 2007.
    Honored by the Dean of college of medicine as one of the top 10 medical graduates (College of Medicine – King Saud University) with an honor degree (GPA = 4.43 out of 5).
    Ranked 5th out of 150 students graduated from the college of Medicine.     .
    Honored as one of the top 10 high school graduates from AlTaif educational center, excellent grade with 99.03%, 2001.
    Ranked 1st and best student in Baha province twice 1996 and 1999.
    Honored as one of the top 10 students in Baha province 4 times 1996, 1999, 2000 and 2001.

Other Certifications:

    Licentiate of the Medical Council of Canada (LMCC) part I and II, 2016.
    Medical Council of Canada Evaluating Examination (MCCEE) in May 2008, scored 355, above 95 percentile.
    Saudi Selection Exam (SLE).
    EBM certificate (evidence based medicine course), February 2008. 
    ECG course certificate 2008.

Publications: 

1-    M. Alzahrani, T. C. El-galaly, M. Hutchings, J. W. Hansen, A. Loft, H. E. Johnsen, V. Iyer, D. Wilson, L. H. Sehn, K. J. Savage, J. M. Connors, Randy D Gascoyne, P. Johansen, E. Clasen-linde, P. Brown, D. Villa: The value of routine bone marrow biopsy in patients with diffuse large B-cell lymphoma staged with PET/CT: A Danish-Canadian study. Annals of Oncology 03/2016; 27(6):mdw137., DOI:10.1093/annonc/mdw137
2-    Chan Yoon Cheah, Martin Hutchings, Kirsty Rady, Kerry J. Savage, Musa F. Alzahrani, Laurie H. Sehn, Sally Barrington, George Mikhaeel, Roopesh R. Kansara, Jakob Werner Hansen, Daniel Smith, Karen Juul Mylam, Thomas Stauffer Larsen, Staffan Holmberg, Maja Juul, Sabrina Cordua, Michael Roost Clausen, Kkristina Buchardi Jensen, Martin Bogsted, Hans Erik Johnsen, Joseph M. Connors, Peter de Nully Brown, John F. Seymour, Diego Villa, Tarec Christoffer El-Galaly: The Absolute Number of Extranodal Sites Detected By PET-CT Is a Powerful Predictor of Secondary Central Nervous Involvement in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP. 57th American Society of Hematology Annual Meeting and Exposition, Orlando, USA.; 12/2015
3-    Tarec Christoffer El-Galaly, Diego Villa, Musa Alzahrani, Jakob Werner Hansen, Laurie H Sehn, Don Wilson, Peter de Nully Brown, Annika Loft, Victor Iyer, Hans Erik Johnsen, Kerry J Savage, Joseph M Connors, Martin Hutchings: Outcome prediction by extranodal involvement, IPI, and R‐IPI in the PET/CT and rituximab era: A Danish‐Canadian study of 443 patients with diffuse‐large B‐cell lymphoma. American Journal of Hematology 08/2015; 90(11)., DOI:10.1002/ajh.24169
4-    Musa Alzahrani, Mark C Hull, Christopher Sherlock, Deborah Griswold, Chantal S Leger, Heather A Leitch: HIV-Associated Multicentric Castleman Disease Refractory to Antiretroviral Therapy: Clinical Features, Treatment and Outcome.. Leukemia and Lymphoma 08/2014; 56(5):1-22., DOI:10.3109/10428194.2014.935368
5-    Musa Al-Zahrani, Kerry J. Savage: Peripheral T-Cell Lymphoma, Not Otherwise Specified. Hematol Oncol Clin North Am. 2017 Apr;31(2):189-207. doi: 10.1016/j.hoc.2016.11.009DOI:10.1016/j.hoc.2016.11.009
6-    Musa Fares Alzahrani, Radwi M.c, Heather A. Leitch: Practical Management of Castleman's Disease. Acta Haematologica 04/2016; Vol. 136, No. 1, 2016(issue in progress):16-22., DOI:10.1159/000444515
7-    Musa F Alzahrani, Maryse M Power, Emilie Nevill, Yasser Abou Mourad, Michael J Barnett, Raewyn Broady, Donna L. Forrest, Alina S. Gerrie, Donna E. Hogge, Stephen H. Nantel, David Sanford, Heather J. Sutherland, Cynthia L. Toze, Kevin W. Song, Thomas J. Nevill, Sujaatha Narayanan: Improving Revised International Prognostic Scoring System (IPSS-R) Pre-Allogeneic Stem Cell Transplant Does Not Translate into Better Post-Transplant Outcomes for Patients with Myelodysplastic Syndromes. ASH, Monday, December 5, 2016, 6:00 PM-8:00 PM Hall GH (San Diego Convention Center); 12/2016
8-    Musa F Alzahrani, Kerry J Savage, Cynthia L. Toze, Laurie H Sehn, Raewyn Broady, Yasser Abou Mourad, Michael J Barnett, Donna L. Forrest, Alina S Gerrie, Donna E. Hogge, Stephen H. Nantel, Sujaatha Narayanan, Thomas J. Nevill, Maryse M Power, David Sanford, David W. Scott, Heather J. Sutherland, Diego Villa, Hilary O'Leary, Joseph M. Connors, Kevin Song: Outcome of Patients with Peripheral T-Cell Lymphoma Undergoing Allogeneic Stem Cell in British Columbia. ASH 2016, San Diego; 12/2016
9-    Diego Villa, Tarec Christoffer El-Galaly, Jakob W. Hansen, Musa Alzahrani, Laurie H. Sehn, Don Wilson, Peter de Nully Brown, Annika Loft, Victor Iyer, Hans E. Johnsen, Kerry J. Savage, Joseph M. Connors, Martin Hutchings: The standard, revised and a simplified International Prognostic Index reliably predict outcome in patients with PET/CT-staged diffuse large B-cell lymphoma treated with R-CHOP. Lugano 2015, Lugano; 06/2015, DOI:10.3252/pso.eu.13icml.2015
10-    Tarec Christoffer El-Galaly, Musa f Alzahrani, Diego Villa, MDMPH, Musa Alzahrani, Jakob Werner Hansen, MD, Laurie H. Sehn, Don Wilson, Peter de Nully Brown, Annika Loft, Victor Iyer, Hans Erik Johnsen, Kerry J. Savage, MDMSc, Joseph M. Connors, Martin Hutchings: Prognostic Impact of Extranodal Diffuse Large B-Cell Lymphoma in the Era of Immunochemotherapy and PET/CT Staging. ASH 2014, San Francisco; 12/2014
11-    Musa f Alzahrani, Tarec Christoffer El-Galaly, Martin Hutchings, Jakob Werner Hansen, Peter de Nully Brown, Annika Loft, Hans E Johnsen, Victor Iyer, Don Wilson, Laurie H. Sehn, Kerry J. Savage, Joseph M. Connors, Diego Villa: Role of Bone Marrow Biopsy in the Staging of Diffuse Large B-Cell Lymphoma in the PET/CT Era. ASH 2014, San Francisco; 12/2014
12-    Musa f Alzahrani, Musa Alzahrani, Mark C Hull, Christopher Sherlock, Deborah Griswold, Chantal S Leger, Shannon Jackson, Christopher P Venner, Tyler W Smith, Heather A Leitch: Clinical Presentation, Treatment and Outcome of HIV-Associated Multicentric Castleman Disease. ASH 2010, Orlando; 12/2010

Poster presentations:

1-    Chan Yoon Cheah, Martin Hutchings, Kirsty Rady, Kerry J. Savage, Musa F. Alzahrani, Laurie H. Sehn, Sally Barrington, George Mikhaeel, Roopesh R. Kansara, Jakob Werner Hansen, Daniel Smith, Karen Juul Mylam, Thomas Stauffer Larsen, Staffan Holmberg, Maja Juul, Sabrina Cordua, Michael Roost Clausen, Kkristina Buchardi Jensen, Martin Bogsted, Hans Erik Johnsen, Joseph M. Connors, Peter de Nully Brown, John F. Seymour, Diego Villa, Tarec Christoffer El-Galaly: The Absolute Number of Extranodal Sites Detected By PET-CT Is a Powerful Predictor of Secondary Central Nervous Involvement in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP. 
o    57th American Society of Hematology Annual Meeting and Exposition, Orlando, USA.; 12/2015
2-    Musa F Alzahrani, Maryse M Power, Emilie Nevill, Yasser Abou Mourad, Michael J Barnett, Raewyn Broady, Donna L. Forrest, Alina S. Gerrie, Donna E. Hogge, Stephen H. Nantel, David Sanford, Heather J. Sutherland, Cynthia L. Toze, Kevin W. Song, Thomas J. Nevill, Sujaatha Narayanan: Improving Revised International Prognostic Scoring System (IPSS-R) Pre-Allogeneic Stem Cell Transplant Does Not Translate into Better Post-Transplant Outcomes for Patients with Myelodysplastic Syndromes. 
o    ASH, Monday, December 5, 2016, 6:00 PM-8:00 PM Hall GH (San Diego Convention Center); 12/2016
3-    Diego Villa, Tarec Christoffer El-Galaly, Jakob W. Hansen, Musa Alzahrani, Laurie H. Sehn, Don Wilson, Peter de Nully Brown, Annika Loft, Victor Iyer, Hans E. Johnsen, Kerry J. Savage, Joseph M. Connors, Martin Hutchings: The standard, revised and a simplified International Prognostic Index reliably predict outcome in patients with PET/CT-staged diffuse large B-cell lymphoma treated with R-CHOP. 
o    Lugano 2015, Lugano; 06/2015, DOI:10.3252/pso.eu.13icml.2015
4-    Tarec Christoffer El-Galaly, Musa f Alzahrani, Diego Villa, MDMPH, Musa Alzahrani, Jakob Werner Hansen, MD, Laurie H. Sehn, Don Wilson, Peter de Nully Brown, Annika Loft, Victor Iyer, Hans Erik Johnsen, Kerry J. Savage, MDMSc, Joseph M. Connors, Martin Hutchings: Prognostic Impact of Extranodal Diffuse Large B-Cell Lymphoma in the Era of Immunochemotherapy and PET/CT Staging.
o    ASH 2014, San Francisco; 12/2014
5-    Musa f Alzahrani, Tarec Christoffer El-Galaly, Martin Hutchings, Jakob Werner Hansen, Peter de Nully Brown, Annika Loft, Hans E Johnsen, Victor Iyer, Don Wilson, Laurie H. Sehn, Kerry J. Savage, Joseph M. Connors, Diego Villa: Role of Bone Marrow Biopsy in the Staging of Diffuse Large B-Cell Lymphoma in the PET/CT Era. 
o    ASH 2014, San Francisco; 12/2014
6-    Musa f Alzahrani, Musa Alzahrani, Mark C Hull, Christopher Sherlock, Deborah Griswold, Chantal S Leger, Shannon Jackson, Christopher P Venner, Tyler W Smith, Heather A Leitch: Clinical Presentation, Treatment and Outcome of HIV-Associated Multicentric Castleman Disease. 
o    ASH 2010, Orlando; 12/2010
Oral presentations:

1-    Clinical Presentation, Treatment and Outcome of HIV-Associated Multicentric Castleman Disease. The internal medicine resident research day 2011, Vancouver, Canada.
2-    Baffling cases in the blood bank. The 3rd Annual Norman Bethune international Symposium, Vancouver Canada (2014).
3-    Role of Bone Marrow Biopsy in the Staging of Diffuse Large B-Cell Lymphoma in the PET/CT Era. BCCA medical oncology research day 2015, BCCA, Vancouver, Canada.
4-    Improving Revised International Prognostic Scoring System (IPSS-R) Pre-Allogeneic Stem Cell Transplant Does Not Translate into Better Post-Transplant Outcomes for Patients with Myelodysplastic Syndromes. The Leukemia/BMT resident/fellow research day 2016, Vancouver, Canada.

Other Research contributions:

    Book chapter on peripheral T-cell lymphoma NOS, published in Hematology Oncology Clinic of North America.(2017).
    Acknowledged after reviewing a book chapter on HIV-associated Hematological Malignancies by Marcus Hentrich Stefan K. Barta Editors.(2015)
    Electronic medication reconciliation through use of preprinted transfer orders in the intensive care unit.  Musa Alzahrani, Dante Wan, Jason Yu, Barbara Hughes, Daniel Negash.
                 -Winner of the QI project.

    Patterns of Child Abuse among Students in Secondary School, Riyadh, Saudi Arabia, presented at a local press. 
    I have provided several peer reviews for multiple scientific journals on articles related to hematology, in particular lymphoproliferative disorders and HIV related lymphomas.  

Skills:

    Clinical skills: 
o    Autologous and allogeneic stem cell transplant.
o    Management of hematological malignancies, with special interest in lymphomas and lymphoproliferative disorders. 
o    General hematology including benign conditions and thrombosis. 
o    Solid background in internal medicine with a special focus on acute medicine care.  
o    Able to perform many procedures including but not limited to: bone marrow aspiration and biopsy, lumbar puncture, bone marrow harvest, skin biopsy, arterial lines, and central lines.

    Health science skills:
o    I have gained strong skills in statistics for health research including: planned collection, numeric and graphic summarization, and elementary statistical analysis of data. I have learned the standard techniques for parametric and non-parametric hypothesis testing; regression and correlation; contingency tables. Also randomization, blinding and other biomedical topics in statistics. 
o    Analytical methods in epidemiological research including: basic epidemiological designs and the commonly used biostatistical techniques such as the Mantel-Haenszel, simple T-test, chi-squared, simple and multilinear regression, logistic regression, Poisson regression, and survival analysis such as Kaplan Meier and Cox-proportional hazard.
o    Methods for systematic reviews in health research including: designing a systematic review, protocol development, searching the published and unpublished medical literature, critical appraisal of clinical trials and application of the Cochrane risk of bias tools within systematic reviews. Also, I have learned the statistical techniques used for data synthesis in systematic reviews and meta-analyses.
o    I took a master course on the scientific basis of epidemiological thinking which included topics on: the scientific method ideology, epistemology, qualitative research, complementary and integrative medicine, health communications, influence of the media, research ethics, and FiLCHeRS method of evidential reasoning. 
o    Epidemiological methods: sources and uses of epidemiologic data for health services planning and administration including methods of data collection and study designs.
o    Applications of principles and methods of epidemiology to clinical problems. Evaluation and design of laboratory and clinical tests and of therapeutic interventions.
o    The design and analysis of Randomized Clinical Trials (RCTs) including: ethical considerations, intention-to-treat versus efficacy trials, principles of sampling and exclusion, methods of allocation and techniques of randomization, parallel versus cross over design, monitoring treatment outcomes, adverse effects, stopping rules, analytic techniques and data interpretation, and logistical issues in the management of clinical trials.
o    I have taken a master course on cancer control and epidemiology that included topics on: collection and analysis of epidemiological data on cancer; genetic, occupational, and other risk factors; analytic techniques; cancer control, prevention, screening, early detection, economic analysis and policy issues.
o    I have also developed skills on dealing with major quantitative research designs, measurement reliability and validity, data sources, internal and external validity, research proposals, and peer review.

    Computer skills:
o    Stat computing using R program and its interface RStudio. My skills in R include: cleaning the data, handling objects matrices and data frames, using the R base functions and creating simple functions and loops, using base and online packages for R, analyzing the data, using commands to calculate many statistical calculations such as chi-squared, t-test etc, producing graphics and plots and saving the output in Git program. 
o    Survival analysis: I have gained skills in performing survival analysis in R including performing Cox-Proportional hazard regression and producing Kaplan Meier (KM) curves. I also have experience in producing KM curves using SPSS software as well.
o    Meta-analysis programs: 
    Review Manger (RevMan): protocol development, performing and producing meta-analysis techniques and plots such as funnel plots, Forest plots, risk of bias tables etc.
    OpenMeta[Analyst] program: calculation of odds ratio, relative risk etc.
o    GRADE: I am able to use different GRADE applications that help in developing guidelines and clinical recommendations. These include: GRADEpro, GRADE DECIDE, risk of bias tools, and summary of evidence tables etc.
o    Reference manager software: I am comfortable with using EndNote X7 for managing bibliographies, citations and references but I also have some past experience with using RefWorks software. 

Interests and Hobbies:

    Patient Education:
o    For example: advocacy project on colon and pancreatic cancer, August 2009 given to Filipino seniors and sponsored by The Guinintuan Seniors Brigade of BC Society.  
    Students Education:
o    For example: I have conducted multiple power point presentations as part of my training in various medical specialties.
o    Conducted multiple clinical teaching sessions for 3rd and 4th year medical students.
    Reading and writing in non-medical topics. 
    Sports: 
o    Very interested in group sports and activities.
o    I enjoy bodybuilding, playing soccer and squash, biking, hiking and swimming.
=======================================